Year |
Citation |
Score |
2020 |
Patidar R, Chen L, Karlovich CA, Das B, Evrard YA, Vilimas T, McCutcheon JN, Peach AL, Nair NV, Forbes TD, Fullmer BA, Fong AJL, Romero LE, Chapman AK, Conley KA, ... ... Alcoser SY, et al. Abstract 3554: Genomic landscape of acquired uniparental disomy in NCI PDMR patient derived xenograft models Cancer Research. 80: 3554-3554. DOI: 10.1158/1538-7445.Am2020-3554 |
0.388 |
|
2019 |
Navas T, Kinders RJ, Lawrence SM, Ferry-Galow KV, Borgel S, Hollingshead MG, Srivastava AK, Alcoser SY, Makhlouf HR, Chuaqui R, Wilsker DF, Konaté MM, Miller SB, Voth AR, Chen L, et al. Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas. Cancer Research. PMID 31732654 DOI: 10.1158/0008-5472.Can-18-3539 |
0.37 |
|
2018 |
Navas T, Pfister TD, Colantonio S, Aziz A, Dieckman L, Saul RG, Kaczmarczyk J, Borgel S, Alcoser SY, Hollingshead MG, Lee YH, Bottaro DP, Hiltke T, Whiteley G, Takebe N, et al. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. Plos One. 13: e0199361. PMID 29928062 DOI: 10.1371/Journal.Pone.0199361 |
0.368 |
|
2017 |
Evrard YA, Ahalt MMG, Alcoser SY, Arthur K, Baldwin M, Blumenauer LL, Bonomi C, Borgel S, Bradtke E, Camalier C, Carter J, Chase T, Chen A, Chen L, Coakley DW, et al. Abstract 3840: The National Cancer Institute’s patient-derived models repository (PDMR) Cancer Research. 77: 3840-3840. DOI: 10.1158/1538-7445.Am2017-3840 |
0.391 |
|
2015 |
Navas T, Pfister TD, Lawrence SM, Srivastava AK, Kinders RJ, Borgel S, Alcoser S, Hollingshead MG, Dutko LM, Gouker BA, Butcher D, Ng-Eaton E, Takebe N, Lee YH, Bottaro DP, et al. Abstract 5082: Impact of HGF knockin microenvironment on epithelial-mesenchymal transition and cancer stem cells in a non-small cell lung cancer xenograft model Cancer Research. 75: 5082-5082. DOI: 10.1158/1538-7445.Am2015-5082 |
0.415 |
|
2015 |
Navas T, Kinders RJ, Lawrence SM, Ferry-Galow K, Pfister TD, Srivastava AK, Alcoser SY, Hollingshead MG, Dutko LM, Gouker BA, Butcher DO, Makhlouf H, Chuaqui R, Bottaro DP, Kummar S, et al. Abstract LB-B18: Epithelial to mesenchymal transition in human tumor biopsies: Quantitative, histopathological proof of the existence of EMT in vivo by immunofluorescence microscopy Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Lb-B18 |
0.363 |
|
2014 |
Hollingshead MG, Stockwin LH, Alcoser SY, Newton DL, Orsburn BC, Bonomi CA, Borgel SD, Divelbiss R, Dougherty KM, Hager EJ, Holbeck SL, Kaur G, Kimmel DJ, Kunkel MW, Millione A, et al. Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies. Bmc Genomics. 15: 393. PMID 24885658 DOI: 10.1186/1471-2164-15-393 |
0.351 |
|
2011 |
Alcoser SY, Kimmel DJ, Borgel SD, Carter JP, Dougherty KM, Hollingshead MG. Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. Bmc Biotechnology. 11: 124. PMID 22176647 DOI: 10.1186/1472-6750-11-124 |
0.334 |
|
2004 |
Alcoser SY, Hara M, Bell GI, Ehrmann DA. Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 89: 2973-6. PMID 15181086 DOI: 10.1210/Jc.2003-031189 |
0.402 |
|
2003 |
Hara M, Wang X, Kawamura T, Bindokas VP, Dizon RF, Alcoser SY, Magnuson MA, Bell GI. Transgenic mice with green fluorescent protein-labeled pancreatic beta -cells. American Journal of Physiology. Endocrinology and Metabolism. 284: E177-83. PMID 12388130 DOI: 10.1152/Ajpendo.00321.2002 |
0.405 |
|
2002 |
Hara M, Alcoser SY, Qaadir A, Beiswenger KK, Cox NJ, Ehrmann DA. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. The Journal of Clinical Endocrinology and Metabolism. 87: 772-5. PMID 11836319 DOI: 10.1210/Jcem.87.2.8255 |
0.357 |
|
Low-probability matches (unlikely to be authored by this person) |
2019 |
Evrard YA, Newton D, Das B, Alcoser SY, Arthur K, Baldwin M, Bonomi C, Borgel S, Carter J, Chase T, Chen A, Chen L, Craig NE, Datta V, Delaney E, et al. Abstract 4524: Comparison of PDX, PDC, and PDOrg models from the National Cancer Institute’s Patient-Derived Models Repository (PDMR) Tumor Biology. DOI: 10.1158/1538-7445.Am2019-4524 |
0.294 |
|
2021 |
El Touny LH, Hose C, Connelly J, Harris E, Monks A, Dull AB, Wilsker DF, Hollingshead MG, Gottholm-Ahalt M, Alcoser SY, Mullendore ME, Parchment RE, Doroshow JH, Teicher BA, Rapisarda A. ATR inhibition reverses the resistance of homologous recombination deficient MGMT/MMR cancer cells to temozolomide. Oncotarget. 12: 2114-2130. PMID 34676045 DOI: 10.18632/oncotarget.28090 |
0.223 |
|
2019 |
Chen L, Patidar R, Das B, Karlovich C, Vilimas T, Camalier C, Datta V, Jiwani S, Walsh W, Fliss P, McDermott S, McCutcheon JN, Peach A, Ahalt-Gottholm M, Bonomi C, ... ... Alcoser SY, et al. Abstract 3385: Comparison of genomic biomarkers identified by the whole exome, RNASeq and whole genome sequencing pipelines developed for the PDMR Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3385 |
0.201 |
|
Hide low-probability matches. |